Citadel Advisors »

Longboard Pharmaceuticals In shares owned by Citadel Advisors

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $873k 26k 33.33
2024-06-30 $530k 20k 27.03
2024-03-31 $3.4M 155k 21.60
2021-03-31 $2.9M 182k 16.16

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Longboard Pharmaceuticals In

Farallon Capital Management
T. Rowe Price Associates
BlackRock
Cormorant Asset Management
BlackRock
Viking Global Investors
Vanguard Group
Woodline Partners
Pictet Asset Management Holding SA
Jennison Associates
Siren
State Street Corporation
Geode Capital Management
Driehaus Capital Management
Parkman Healthcare Partners

View all funds holding Longboard Pharmaceuticals In